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Abstract
Background: Adolescents with attention-deficit/hyperactivity disorder (ADHD) are known to be at significantly greater risk
for the development of substance use disorders (SUD) compared to peers. Impulsivity, which could lead to higher levels of
drug use, is a known symptom of ADHD and likely accounts, in part, for this relationship. Other factors, such as a biologically
increased susceptibility to substance dependence (addiction), may also play a role.
Objective: This report further examines the relationships between childhood ADHD, adolescent- onset SUD, and substance
abuse and substance dependence in adulthood.
Method: Individuals with childhood ADHD and non-ADHD controls from the same population-based birth cohort were
invited to participate in a prospective outcome study. Participants completed a structured neuropsychiatric interview with
modules for SUD and a psychosocial questionnaire. Information on adolescent SUD was obtained retrospectively, in a
previous study, from medical and school records. Associations were summarized using odds ratios (OR) and 95% CIs
estimated from logistic regression models adjusted for age and gender.
Results: A total of 232 ADHD cases and 335 non-ADHD controls participated (mean age, 27.0 and 28.6 years, respectively).
ADHD cases were more likely than controls to have a SUD diagnosed in adolescence and were more likely to have alcohol
(adjusted OR 14.38, 95% CI 1.49–138.88) and drug (adjusted OR 3.48, 95% CI 1.38–8.79) dependence in adulthood. The
subgroup of participating ADHD cases who did not have SUD during adolescence were no more likely than controls to
develop new onset alcohol dependence as adults, although they were significantly more likely to develop new onset drug
dependence.
Conclusions: Our study found preliminary evidence that adults with childhood ADHD are more susceptible than peers to
developing drug dependence, a disorder associated with neurological changes in the brain. The relationship between ADHD
and alcohol dependence appears to be more complex.
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Introduction
Individuals with attention-deficit/hyperactivity disorder
(ADHD) are known to be at significantly greater risk for the
development of substance use disorders (SUD) compared to their
non-ADHD peers. [1–3] The Diagnostic and Statistical Manual of
Mental Disorders, Fourth Edition-Text Revision (DSM-IV-TR)
had defined two types of SUDs: substance abuse (substance use
that interferes with daily functioning or is associated with recurrent
problems) and substance dependence (manifested by an intense
desire for the drug of choice and loss of control over use). [4] (The
nomenclature was changed to mild-, moderate- or severe- SUD in
the Diagnostic and Statistical Manual of Mental Disorders, Fifth
Edition (DSM-5), [5] with ‘‘substance abuse’’ roughly correlating
to moderate SUD and ‘‘substance dependence’’ to severe SUD. In
this manuscript we will use the terms ‘‘abuse’’ and ‘‘dependence’’
because we are reporting on data from a standardized neuropsy-
chiatric interview that was validated based on DSM-IV terms and
definitions.) Research over the past decade has revealed that
substance dependence (addiction, or severe SUD) is a neurolog-
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reward center of the brain. This disruption results from repeated
exposure to a psychoactive substance. [6–8] While substance abuse
and substance dependence are grouped together as ‘‘substance use
disorders’’, they are clearly different: substance dependence
involves a distinct pattern of neurological changes caused by
repeated exposure to a psychoactive substance, while substance
abuse does not.
Human brain development occurs in an orderly, rostral-caudal
progression. Notably, the nucleus accumbens, sometimes referred
to as the ‘‘reward center,’’ is mature by mid-adolescence, while the
maturation of the pre-frontal cortex continues until the mid-209s.
[9] A body of epidemiologic data and analysis has established that
the earlier an individual initiates psychoactive substance use, the
more likely she or he is to ultimately develop substance
dependence, with a near linear relationship. [10–13] In the
population at large, by early adulthood, individuals seem to
develop a relative resistance to substance dependence and the
incidence falls dramatically. The declining incidence is thought to
be related in part to maturation of the pre-frontal cortex [14,15]
and attendant maturation of ‘‘executive functions.’’
Previously, we reported on the association between ADHD and
SUD prior to 18 years of age among research-identified childhood
ADHD cases and controls from a population-based birth cohort.
[1] Our childhood ADHD cases were 6.2 times more likely (95%
CI=4.0–9.4; p,0.001) to have an alcohol/drug use disorder
documented in their medical and/or school records than non-
ADHD controls from the same birth cohort. Other investigators
have also clearly demonstrated this relationship. [16–18] In our
previous study, the association between ADHD case status and
SUD was consistent for both boys and girls. Stimulant treatment
tended to be protective, especially in boys, with significantly fewer
stimulant-treated boys having a documented SUD during
adolescence compared to boys with ADHD who were not treated
with stimulants. [1].
The mechanisms underlying the relationship between ADHD
and SUD are not fully understood, and previous research has not
distinguished between substance abuse and substance dependence
among individuals with ADHD. This distinction, however, may
help to elucidate the complex relationship between the two
disorders. This report examines the relationships between ADHD,
substance abuse, and substance dependence among adults with
research-identified childhood ADHD versus controls in order to
explore whether individuals with ADHD are more susceptible to
developing the neurological disorder of substance dependence in
adulthood, after the typical period of heightened vulnerability in
adolescence.
Methods
Study Setting
Rochester, Minnesota is geographically isolated in southeastern
Minnesota and virtually all medical care for residents of Rochester
is provided by Mayo Clinic, Olmsted Medical Center, and their 3
affiliated hospitals. The resources of the Rochester Epidemiology
Project (REP) provide infrastructure for population-based re-
search. [19,20] All medical diagnoses and surgical procedures are
recorded and indexed for computerized retrieval. For this ADHD
study, all 41 public and private schools in Minnesota Independent
School District 535 (city of Rochester school system) participated
in a contractual research agreement that gave us permission to
access their cumulative educational records for every child from
the 1976–1982 Rochester, MN birth cohort. Written informed
consent was obtained from all participants in the prospective
portion of this study. The study was approved by the Institutional
Review Boards of Mayo Clinic and Olmsted Medical Center.
Retrospective Phase of the Study
Birth Cohort. This study employed a birth cohort consisting
of all children born between January 1, 1976, and December 31,
1982, to mothers residing in the townships comprising Minnesota
Independent School District 535, who continued to live in
Rochester until at least age 5 years (N=5718). Nineteen subjects
with severe intellectual disability were subsequently excluded.
Identification of Childhood ADHD Cases and
Controls. Our approach to identify ADHD incidence cases
consisted of several steps, used multiple sources of information,
and relied on recorded history of symptoms, individual test results
(psychological assessments, including ADHD rating scales), and
treatment documented in medical and school records that were
available for all members of the birth cohort. Details of this process
were previously reported. [21] Briefly, several steps were used to
narrow the pool of potential ADHD incident cases, starting with
cumulative school records of each child in the birth cohort
(n=5718). School records were searched for indications of
concern about learning and/or behavior; 1961 children were
identified with such concerns documented by teachers, parents,
school psychologists, physicians, social workers, or/and school
nurses. Next, we abstracted all descriptions of ADHD symptoms
consistent with DSM-IV, results from teacher/parent ADHD
questionnaires and clinical diagnoses of ADHD from school and
medical records.
Identification of ADHD incident cases consisted of applying
research criteria to these 1961 children. Subjects were defined as
research-identified ADHD incident cases if their school/medical
records included various combinations of three different categories
of information: 1) met DSM-IV criteria for ADHD, 2) positive
ADHD questionnaire results, 3) clinical diagnosis of ADHD. A
total of 379 childhood ADHD incident cases were identified.
Research diagnostic criteria were met at a mean age of 10.4 years.
Non-ADHD controls were identified from the remaining members
of the birth cohort who were in the community after 5 years of
age, and who had not fulfilled research criteria for childhood
ADHD.
Identification of Childhood Psychiatric Disorders among
ADHD Cases and Controls. Details regarding the identifica-
tion of co-occurring psychiatric disorders in childhood among
ADHD cases and controls in this birth cohort are described
elsewhere, [21] and consisted of a systematic, multistage process,
utilizing detailed, routinely collected data as part of the Rochester
Epidemiology Project. [19] This process included systematic
abstraction of data from the medical records of ADHD cases
and controls. To be classified with a psychiatric disorder in this
study, we required documentation of (a) the initial diagnosis and
(b) separate confirmation of the initial diagnosis prior to 18 years of
age.
Identification of Adolescent Onset SUD’s among ADHD
Cases and Controls. Information about alcohol and/or drug
abuse was available in school records (e.g., school psychologist
notes, guidance counselor reports, summaries of school assess-
ments, social workers’ notes) and/or medical records (social
worker, psychology and psychiatry records including correspon-
dence regarding treatment for substance abuse provided by private
treatment facilities). The school and medical records of each of the
ADHD case and control subjects were reviewed by trained
abstractors using a detailed protocol, for documentation of a
clinical diagnosis of SUD. Additionally, the computerized Medical
Diagnostic Index was also searched for any diagnosis related to or
Childhood ADHD and Risk for Substance Dependence in Adulthood
PLOS ONE | www.plosone.org 2 August 2014 | Volume 9 | Issue 8 | e105640including ‘‘substance use disorder’’ among the 379 childhood
ADHD cases under study and their matched controls. Adolescent
onset ‘‘substance use disorder’’ required documentation of SUD in
the medical and or school records prior to 18 years of age. [1].
Stimulant Medication Treatment. Medical and school
records for every member of the birth cohort were reviewed and
all documentation about treatment with stimulant medications was
abstracted. We have previously described stimulant treatment
among this cohort of ADHD cases, including age of onset, dosage,
and duration of treatment throughout childhood. [22].
Prospective Phase of the Study
Recruitment for Prospective Study. Of the 379 subjects
with research-identified childhood ADHD identified in our
retrospective study, 362 provided continued permission to access
their medical records for research and were invited to participate
in the adult outcome study. To ensure enrollment of sufficient
non-ADHD controls, a random sample of 801 adults from the
same birth cohort was also invited to participate. Five control
subjects in the prospective study stated they had received a
diagnosis of childhood ADHD. We reviewed records from these 5
subjects and determined that they had fulfilled our research
criteria for childhood ADHD, but had not been thus classified
previously because they had moved from the community before
receiving this diagnosis or because of the timing of the original
data abstraction. These 5 subjects were therefore reclassified as
childhood ADHD cases for all analyses presented in this paper.
Identification of Adult Psychiatric Disorders and SUDs
among Childhood ADHD Cases and Controls. All partici-
pants in the prospective study were administered the Mini
International Neuropsychiatric Interview (M.I.N.I), including the
module for Adult ADHD. [23,24] The M.I.N.I. is a structured
diagnostic interview for DSM-IV-TR and ICD-10 psychiatric
disorders. Psychiatric disorders were determined by symptoms
consistent with DSM-IV TR/ICD 10 as specified by the M.I.N.I.
The M.I.N.I. includes modules on ‘‘Alcohol Abuse and
Dependence’’. Each subject was first asked, ‘‘In the past 12
months, have you had 3 or more alcoholic drinks within a 3 hour
period on 3 or more occasions?’’ All subjects responding ‘‘yes’’ to
this first item were then asked a series of questions to determine
classification as current alcohol dependence or current alcohol
abuse. For the purposes of this study, subjects who reported
consuming 3 alcoholic drinks within a 3 hour period on 3 or more
occasions, but who did not meet criteria for alcohol abuse or
dependence, were defined as having heavy alcohol use. Alcohol
abuse and alcohol dependence were defined as per the M.I.N.I.
Because the M.I.N.I does not ask about lower levels of alcohol use,
subjects who did not report ‘‘heavy drinking’’ were defined as no
heavy alcohol use. The M.I.N.I. also includes modules for ‘‘Non-
Alcohol Psychoactive Substance Use Disorders.’’ The latter
modules are completed for each psychoactive substance used in
the past 12 months to ‘‘get high, to feel better, or to change your
mood.’’ According to the M.I.N.I. administration protocol, a
diagnosis of ‘‘dependence’’ pre-empts a diagnosis of ‘‘abuse’’ for all
substances. For the purposes of this study, we defined any illicit
substance use that did not meet criteria for drug abuse or
dependence as drug use without a disorder. Drug abuse and drug
dependence were defined as per the M.I.N.I., and drug exposure
was defined as drug use, drug abuse, or drug dependence.
SUD Treatment. All subjects completed an extensive
psychosocial questionnaire that included specific questions about
having participated in a treatment program for ‘‘alcohol or
drinking problems’’, ‘‘marijuana use,’’ or ‘‘other street drugs or
hard drugs.’’
Statistical Methods. Characteristics were compared be-
tween participating and non-participating ADHD cases and
between participating ADHD cases and participating non-ADHD
controls using the two-sample t-test for age, the Fisher’s exact test
for race, and the chi-square test for all other categorical variables.
Current SUD outcomes in young adulthood (as determined from
the M.I.N.I.) were first compared overall between individuals with
childhood ADHD and non-ADHD controls and then separately
stratified by adolescent onset SUD. The association between the 4-
level current drug exposure status (no use, drug use without a
disorder, abuse, dependence) and ADHD case status was assessed
based on fitting a generalized logits model. The association
between current drug dependence and ADHD case status was
assessed based on fitting a binary logistic regression model. All
logistic regression models included gender and age at participation
and all reported odds ratios (OR) are reported as ORs adjusted for
age and gender unless otherwise noted. The same approach was
used to analyze current alcohol exposure. The Sobel test was used
to test whether the estimate of mediation for co-occurring
childhood psychiatric diagnoses was statistically significant. [25]
All calculated p-values were two-sided and p-values less than 0.05
were considered statistically significant. Analyses were performed
using SAS version 9.2 software (SAS Institute, Inc.; Cary, NC;
2010).
Results
Description of Participants in the Prospective Phase of
the Study
Participating adults with childhood ADHD (n=232) were
similar to non-participants (n=152) in regard to gender, age,
ethnicity, rates of co-occurring mental health disorders, and
stimulant treatment history. Control subjects were slightly older at
the time of follow-up participation, more likely to be female, and
significantly less likely to have had a co-occurring mental health
disorder during childhood as compared to ADHD cases (Table 1).
Substance Use Disorders in Adolescence and Adulthood
Among ADHD Cases and Controls
ADHD cases were significantly more likely to have SUD
diagnosed during adolescence compared to controls (23.7% vs.
4.5%; unadjusted OR 6.63, 95% CI 3.64–12.08; Table 1). Among
the 55 ADHD cases with adolescent onset SUD, the median age of
SUD documented in the medical and school records was 16.3
years (range 13.2–18.0), while among the 15 controls with
adolescent onset SUD, median age of SUD was 16.9 years (range
15.4–17.8). ADHD cases were also more likely to meet criteria for
drug dependence (10.8% vs. 2.7%; adjusted OR 4.42, 95% CI
1.95–9.99, p,0.001) and alcohol dependence (14.7% vs. 8.7%;
adjusted OR 1.87, 95% CI 1.07–3.27, p=0.03) in adulthood.
Marijuana was the most common substance of dependence among
participating cases and controls (Table 2).
Drug Use in Adulthood by Adolescent Onset SUD Status
Among the subgroup of participants who did not have
adolescent onset SUD, rates of drug exposure in adulthood (i.e.
drug use, drug abuse or drug dependence) were higher in
adulthood among ADHD cases compared with controls (27.7%
vs. 18.1%, Table 3). Notably rates of drug use and abuse were
similar while ADHD cases were approximately 3.5 times more
likely to develop drug dependence (vs. no drug use) compared to
controls (adjusted OR 3.48, 95% CI 1.38–8.79, p=0.01). Simply
put, as ADHD cases grew into adults, they were both more likely
to use drugs and more likely to develop new onset drug
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occurring childhood psychiatric diagnoses, which accounts for
39.2% of the association (p=0.014).
Among the individuals who did have adolescent onset SUD,
rates of drug exposure in adulthood tended to be higher in ADHD
cases as compared to controls (49.1% vs. 20.0%; Table 3).
However, given the limited sample size, we were unable to
identify significant differences in the rates of non-alcohol drug use,
drug abuse, or drug dependence in adulthood between ADHD
cases and controls who had adolescent onset SUD.
Alcohol Use in Adulthood by Adolescent Onset SUD
Status
Among the subgroup of individuals with adolescent-onset SUD,
those with ADHD were significantly more likely to have alcohol
dependence (vs. no heavy alcohol use) as adults compared to
controls (29.1% vs. 6.7%; adjusted OR 14.38, 95% CI 1.49–
138.88, p=0.02; Table 4). Our findings on alcohol dependence
among the subgroup of adults who did not have a SUD in
adolescence were distinctly different. In this group, ADHD cases
were less likely to report heavy alcohol use (i.e. 3 or more drinks in
a 3 hour period) (adjusted OR 0.56, 95% CI 0.36–0.88, p=0.01)
while there were no differences in the rates of alcohol abuse
Table 1. Comparison of demographic factors, co-occurring mental health disorders and stimulant treatment among participating
ADHD cases, non-participating ADHD cases and controls.
Characteristic ADHD cases
Participating Non-
ADHD Controls
(N=335)
Participating ADHD
cases vs. Non-
participating
ADHD cases,
Participating ADHD
cases
vs. Participating
Non-ADHD controls, P
Participating
ADHD cases
(N=232)
Non-Participating
ADHD cases
(N=152)
Male, n (%) 167 (72.0) 121 (79.6) 210 (62.7) 0.09 0.02
Age at time of
participation (years)
Mean (SD) 27.0 (2.6) – 28.6 (2.2) – ,0.001
Range 21.7–33.5 – 24.3–33.8 –
White, n (%) 231 (99.6) 150 (98.7) 329 (98.2) 0.57 0.25
Received stimulant
treatment, n (%)
178 (76.7) 119 (78.3) – 0.72 –
Psychiatric diagnosis
prior to age 18,
n( % )
Unknown, n 0 17{ 0 0.92 ,0.001
No 101 (43.5) 58 (43.0) 281 (83.9)
Yes 131 (56.5) 77 (57.0) 54 (16.1)
Substance use disorder
(SUD) prior to age 18,
n( % )
Unknown, n 0 17{ 0 0.75 ,0.001
No 177 (76.3) 105 (77.8) 320 (95.5)
Yes 55 (23.7) 30 (22.2) 15 (4.5)
{Seventeen of the non-participating ADHD cases had not authorized access to their medical records for research purposes at the time of the abstraction of these two
parameters.
doi:10.1371/journal.pone.0105640.t001
Table 2. Subjects with drug dependence in adulthood, by substance
{.
Substance ADHD Cases N=232 Controls N=335
Marijuana 16 6
Cocaine 11 4
Stimulants 10 2
Narcotics
` 31
Tranquilizers* 3 0
Hallucinogens
{{ 20
{Some subjects were found to be dependent on more than one substance. A total of 18 ADHD cases and 5 controls were dependent on substances other than
marijuana.
`Includes heroin, morphine, Dilaudid, opium, Demerol, methadone, codeine, Percodan, Darvon, OxyContin.
*Includes quaalude, Seconal (‘‘reds’’), Valium, Xanax, Librium, Ativan, Dalmane, Halcion, barbituates, Miltown.
{{Includes LSD (‘‘acid’’), mescaline, peyote, PCP (‘‘Angel dust’’, ‘‘peace pill’’), psilocybin, STP, ‘‘mushrooms’’, ecstasy, MDA, MDMA.
doi:10.1371/journal.pone.0105640.t002
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(adjusted OR 0.94, 95% CI 0.47–1.89, p=0.86).
Persistence of Alcohol and Non-Alcohol Substance
Dependence from Adolescence to Adulthood
The complex relationship between childhood ADHD, adoles-
cent- onset SUD, and adult SUD’s are summarized in Figure 1.
The overall rate of persistent SUD from adolescence into young
adulthood was higher among childhood ADHD cases versus
controls (19/232 or 8.2% versus 2/335 or 0.6%; p,0.001).
Among the subgroup of subjects with adolescent-onset SUD, SUD
persisted into adulthood for 34.6% for ADHD cases (19/55) versus
13.3% for controls (2/15). This finding was not statistically
significant (p=0.20) due to limited power, with only 15 controls
having adolescent-onset SUD.
Impact of Stimulant Treatment in childhood on
Substance Dependence in Adulthood
Our previous, retrospective review of records found that 178 of
the 232 ADHD cases received stimulant treatment in childhood,
and information about the age at which stimulants were started
and duration of treatment was available for 167. [23] Subjects who
were treated for 6 months or longer (n=139) were considered
‘‘treated’’ for analyses of the association between stimulant
treatment in childhood and substance dependence in adulthood.
For analyses of the association between stimulant treatment and
risk for adult drug or alcohol dependence, we dichotomized
subjects into those who received any treatment after the age of 13
years (n=114) versus those who only received treatment prior to
age 13 years (n=25). We found no association between timing of
stimulant treatment during childhood and classification as adult
drug or alcohol dependence when each of these outcomes were
analyzed separately; however, the combined risk for either adult
drug or alcohol dependence was higher among subjects who had
received at least some stimulant treatment after age 13 years
(Table 5). Furthermore, there was no association between age of
initiation, dosage, or duration of stimulant treatment and risk for
SUD (data not shown).
Impact of ADHD on treatment for substance dependence
We calculated the rates of substance dependence among ADHD
cases and controls who had received any form of treatment for a
SUD to examine whether ADHD moderated SUD treatment
effects. Overall, we found that individuals with ADHD were more
likely than controls to have received treatment for alcohol,
marijuana, or other drug use disorders (26.7% vs. 9.3%; adjusted
OR 3.37, 95% CI, 2.05–5.54, p,0.001). Forty-seven ADHD cases
and 19 controls reported treatment for alcohol disorders. Among
study participants who received treatment for an alcohol disorder,
ADHD cases were more likely to have alcohol dependence in
adulthood compared with controls (40.4% (19/47) vs. 15.6% (3/
Table 3. Current drug use, abuse and dependence among adults with versus without childhood ADHD, stratified by substance use
disorder prior to 18 years of age.
Current Status Adolescent Onset SUD=No Adolescent Onset SUD=Yes
ADHD Cases
(N=177)
Non-ADHD
(N=320)
Adjusted OR
`
(95% CI), P
ADHD Cases
(N=55)
Non-ADHD
(N=15)
Adjusted OR
`
(95% CI), P
No drug use 128 (72.3%) 262 (81.9%) Referent 28 (50.9%) 12 (80.0%) Referent
Drug use without
a disorder
28 (15.8%) 38 (11.9%) 1.11 (0.63–1.98), 0.72 10 (18.2%) 1 (6.7%) 5.17 (0.56–47.86), 0.15
Drug abuse 6 (3.4%) 12 (3.8%) 0.81 (0.28–2.36), 0.69 7 (12.7%) 1 (6.7%) 2.97 (0.30–29.24), 0.35
Drug dependence 15 (8.5%) 8 (2.5%) 3.48 (1.38–8.79), 0.01 10 (18.2%) 1 (6.7%) 5.97 (0.64–55.61), 0.12
OR, odds ratio; CI, confidence interval.
{Drug (non-alcohol) substances include the following: stimulants, cocaine, narcotics, hallucinogens, inhalants, marijuana, and tranquilizers. In order to create mutually
exclusive categories, each individual’s overall current non-alcohol substance use status was classified as the most severe status among all substances.
`Adjusted for age and gender.
*Adjusted for age.
doi:10.1371/journal.pone.0105640.t003
Table 4. Current heavy alcohol use, abuse and dependence among adults with versus without childhood ADHD, stratified by
substance use disorder prior to 18 years of age.
Current Status Adolescent Onset SUD=No Adolescent Onset SUD=Yes
ADHD Cases
(N=177)
Non-ADHD
(N=320)
Adjusted OR
`
(95% CI), P
ADHD Cases
(N=55)
Non-ADHD
(N=15)
Adjusted OR
`
(95% CI), P
No heavy alcohol use 77 (43.5%) 125 (39.1%) Referent 14 (25.5%) 9 (60.0%) Referent
Heavy alcohol use 60 (33.9%) 146 (45.6%) 0.56 (0.36–0.88), 0.01 20 (36.4%) 4 (26.7%) 3.12 (0.73–13.29), 0.12
Alcohol abuse 22 (12.4%) 21 (6.6%) 1.31 (0.64–2.71), 0.46 5 (9.1%) 1 (6.7%) 3.24 (0.29–36.65), 0.34
18 (10.2%) 18 (10.2%) 28 (8.8%) 0.94 (0.47–1.89), 0.86 16 (29.1%) 1 (6.7%) 14.38 (1.49–138.88), 0.02
OR, odds ratio; CI, confidence interval.
{Adjusted for age and gender.
*Adjusted for ag.
doi:10.1371/journal.pone.0105640.t004
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participants had received treatment for marijuana or another drug
disorder, and we did not find statistically significant effects for
other substances.
Discussion
Our study provides initial evidence that individuals with
childhood ADHD remain more susceptible than peers (without
ADHD) to developing new onset drug dependence, a disorder
associated with neurological changes in the brain, in adulthood.
This finding suggests that early onset drug use, a factor known to
increase the risk of developing substance dependence, does not
fully account for the relationship between ADHD and SUD.
Overall, the rate of drug exposure (i.e. drug use or drug abuse or
drug dependence) was higher in adults with ADHD, suggesting
that impulsivity and poor decision-making continue to play a role.
However, among individuals who reported any drug use as adults,
rates of new onset drug dependence was significantly higher
among ADHD cases – suggesting that the relationship is multi-
factorial and not fully explained simply by a greater propensity to
use drugs. Furthermore, our findings suggest that individuals with
ADHD are more likely than their non-ADHD peers to have
persistence of substance dependence in young adulthood. Our
data did not allow us to evaluate the relationship between
individual drugs and adult onset substance dependence because of
small cell sizes, and it is possible that results vary depending on
substance. We note that marijuana was the most frequently used
drug by adult participants in this study. It is important to note that
Figure 1. Adolescent SUD and adult substance dependence outcomes for childhood ADHD incident cases and controls. *Individuals
with both ‘‘drug’’ dependence and alcohol dependence are coded as drug dependent in these figures. Individuals coded as alcohol dependent did
not meet dependence criteria for any other substance.
doi:10.1371/journal.pone.0105640.g001
Table 5. Impact of stimulant treatment in childhood on substance dependence in adulthood.
Substance Dependence Status Stimulant treatment ended before age 13 (N=25) Stimulant treatment ended after age 13 (N=114) P value
Alcohol dependence 1 (4.0%) 19 (16.7%) 0.125
Substance dependence 1 (4.0%) 12 (10.5%) 0.463
Alcohol or substance dependence 1 (4.0%) 25 (21.9%) 0.046
doi:10.1371/journal.pone.0105640.t005
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when members of this birth cohort were children or adolescents, so
these findings cannot be attributed to clinician recommendations.
Most importantly, while some advocates for ‘‘medical’’ marijuana
have suggested marijuana as a potential therapy for ADHD, our
findings of heightened susceptibility to adult onset substance
dependence give reason for pause.
The pre-frontal cortex is an area of the brain that has been
implicated in ADHD, [26–28] and poor executive functioning is
one of the core features of the disorder. [29–32] Perhaps not
surprisingly, we found that adults with a history of childhood
ADHD who did not have a SUD during adolescence were
nevertheless significantly more likely than controls to develop drug
dependence, a condition known to be associated with poor
executive functioning during young adulthood. This finding is
mediated by the presence of co-occurring mental health disorders,
and we speculate that the maturation of executive functions might
be further slowed in individuals with a mental health disorder,
leaving them at very high risk for using drugs and developing drug
dependence. This group should be counseled to avoid drugs and
should be carefully monitored for SUDs beyond adolescence.
Our findings regarding alcohol use were different. Individuals
with childhood ADHD and adolescent SUD were more likely to
have alcohol dependence in adulthood. However, ADHD cases
that did not develop a SUD in their teens were less likely than
peers to drink heavily and they were not at increased risk for
developing new onset alcohol dependence.
While all substances of abuse have action in the brain’s ‘‘reward
center,’’ alcohol’s mechanism of action is distinct. Unlike
marijuana and most other illicit substances, alcohol freely crosses
cell membranes and exerts its actions on a variety of targets, rather
than via a specific receptor. Alcohol dependence is highly
heritable, with some individuals particularly prone to developing
alcohol use disorders and others relatively resistant. For example,
specific alleles for genes that encode alcohol dehydrogenase appear
to be protective against alcoholism. Animal studies have found that
the neuronal sensitivity to alcohol induced excitation is lower in
mice that are bred to be ‘‘heavy drinkers.’’ [33].
We speculate that individuals with ADHD can be divided into
two groups regarding liability for developing alcohol dependence.
Individuals with a ‘‘high liability’’ develop alcohol use disorders in
adolescence and have persistent alcohol dependence in adulthood.
In other words, adolescents with ADHD may be less likely to
‘‘outgrow’’ an alcohol use disorder than their peers. As in reports
from other authors, we found that treatment for SUD is less
effective in this group. [34–39] On the other hand, individuals
with ADHD who have a ‘‘lower liability’’ for alcohol problems
may be less likely to drink heavily which may be protective from
developing alcohol use disorders in both adolescence and
adulthood. We cannot tell from our data whether this ‘‘liability’’
is inborn or present early in life, or the result of refraining from
substance use during adolescence. Whatever the mediators, they
seem to be specifically related to alcohol regulation and do not
protect individuals from developing drug dependence as adults.
While the causes remain unclear, it seems prudent to counsel
adolescents with ADHD to avoid alcohol use. The National
Institute on Alcohol Abuse and Alcoholism (NIAAA) has
recommended alcohol screening and brief intervention for
children as young as 9 years old, the age prior to initiation of
alcohol use for most individuals. [40] Our findings highlight the
importance of preventative alcohol counseling, particularly for
individuals with ADHD.
In our previous retrospective study of the association between
stimulant treatment and risk for SUD through adolescence in this
cohort of childhood ADHD cases, we found that among boys who
were treated, 21.8% had substance abuse compared to 36.4% for
those not treated. [1] However, among girls who were treated
(N=10), 15.2% had substance abuse compared to 10.3% of those
not treated, although the total number of girls with SUD in
adolescence was small (n=13). In the current, prospective study of
SUD outcomes in adulthood, subjects who received stimulant
treatment for at least 6 months, and who received some treatment
after age 13 years, were at greater risk for adult drug or alcohol
dependence than subjects who only received stimulant treatment
prior to age 13 years. Given our finding of increased risk for SUD
developing after adolescence among ADHD cases, it should not be
surprising that stimulant treatment ending in mid-adolescence
would be unlikely to continue to protect against the subsequent
development of drug or alcohol dependence. Furthermore,
although it cannot be determined from our dataset, subjects who
continued to receive treatment after age 13 years may have had
more severe ADHD symptoms and hence may have been at
greater risk for development of SUD. Future studies that ensure
continued stimulant treatment of ADHD through young adult-
hood may offer an opportunity to better understand the potential
impact of stimulant treatment on risk for SUD into adulthood.
Our study has a number of strengths. Our data came from a
large, population-based birth cohort and did not depend on a
sample referred for ADHD treatment, which typically over
represents individuals with the most challenging disorders. Our
birth cohort was large, retrospective data was extensive, and our
prospective data included a comprehensive, structured neuropsy-
chiatric interview, making our data set unique among published
studies of ADHD outcomes. We also note a number of limitations.
Our retrospective data did not include age of initiation of
substance use, which was not routinely noted in the medical
record. Thus, we were unable to evaluate the relationship between
age of initiation of substance use and outcomes. Retrospective data
were not sufficiently detailed to distinguish between substance
abuse and substance dependence during adolescence nor to
determine which substances were used during adolescence. Our
control group was well matched on demographic measures,
though co-occurring mental health disorders were more common
in ADHD cases than controls, and these disorders play a role in
the relationship between ADHD and SUD. It is also possible that
other, unmeasured factors may confound our findings. Although
our initial cohort of ADHD cases was large, the number of subjects
with adolescent-onset SUD followed into adulthood was smaller,
contributing to relatively large confidence intervals around
estimates of rates of adult SUD in this sub-group; hence, these
specific results should be interpreted with caution.
Conclusions
This report is the first to utilize a population-based birth-cohort
to examine the relationship between childhood ADHD and SUD
during young adulthood and to describe differential rates of new
onset substance dependence in adults with a history of childhood
ADHD. Our findings make an important contribution in
understanding the intersection between these two common
disorders. Most importantly, our findings underscore the impor-
tance of continuous monitoring, prevention and early intervention
for substance use among children, adolescents, and adults with
ADHD to prevent the development of substance dependence.
Further study is needed to determine the most effective
mechanisms for achieving these goals.
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